next ride motor inc

164 donovan street
suite #5
webster, new york 14580

NYS Entity Status
ACTIVE

NYS Filing Date
JULY 26, 2013

NYS DOS ID#
4436767

County
MONROE

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC BUSINESS CORPORATION

Name History
2013 - NEXT RIDE MOTOR INC









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • Uber Racks Up Rides, Losses Amid Setbacks
    Wednesday Aug 23, 2017

    Uber Technologies Inc.’s scandal-plagued year apparently hasn’t deterred ridership, though the ride-hailing company is still reporting heavy financial losses.

    Source: The Wall Street Journal: Technology: What's News
  • SUMMER FIRSTS | Brooklyn: Finding Alchemy and Art on a Coney Island Scary Ride
    By FRANCINE PROSE - Wednesday Aug 2, 2017

    For Francine Prose, an amusement-park trip as a young girl led to a ride on the Spook-a-Rama and later to a prized Diane Arbus photo of the same ride.

    Source: NYT > Home Page
  • In Pivotal Moment, Tesla Unveils Its First Mass-Market Sedan
    By BILL VLASIC - Saturday Jul 29, 2017

    Elon Musk, Tesla’s chief executive, delivered 30 cars to employees chosen to be the first owners. The electric-car maker faces a challenge in meeting the sizable demand.

    Source: NYT > Home Page
  • Tesla Yields Place Atop U.S. Automakers as Stock Slumps
    By NEAL E. BOUDETTE - Thursday Jul 6, 2017

    The electric-car maker’s shares are off sharply after a report of production trouble, giving General Motors back its No. 1 spot after less than three months.

    Source: NYT > Home Page
  • Uber and Yandex, a Russian Ride-Hailing Rival, Opt to Share the Road
    By MIKE ISAAC - Thursday Jul 13, 2017

    The competitors have decided to stop battling for market share and instead operate jointly in a handful of Eastern European countries.

    Source: NYT > Home Page
  • Cancer drug research moving fast in immunotherapy field
    By Michelle Fay Cortez - Tuesday Sep 5, 2017

    The last few weeks have been historic in the fight against cancer. Novartis got approval for the first treatment in a revolutionary new class of drugs, shortly after Gilead Sciences Inc. spent $11.9 billion on a biotech company working in the field. Neither can rest on its laurels. Research in the field is moving so fast that today’s breakthroughs can easily become tomorrow’s has-beens. “I can’t think of any other therapies in oncology that have seen such rapid development,” said Rachel Webster, senior director of oncology at Decision Resources Group, a health care research and consulting firm in London.

    Source: SFGATE.com: Business and Technology News
next ride motor inc webster ny